Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in the United States and Mexico

PREVENT-19 will assess the efficacy, safety and immunogenicity of NVX-CoV2373 in the prevention of COVID-19 Trial to enroll up to 30,000 volunteers across approximately 115 sites in the U.S. and Mexico Two-thirds of enrollees to receive active vaccine GAITHERSBURG, Md., Dec. 28, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing […]

Read More

2021 Investment Outlook: Asia and Emerging Markets poised to lead global economic recovery

K-shape global recovery likely amid continued divergence in growth among different markets and industries. More eyes on emerging markets and Asia as region looks on track to reopening. Lower-for-longer interest-rate environment pushes investors further out the risk curve to search for income. HONG KONG and SINGAPORE, Dec. 28, 2020 (GLOBE NEWSWIRE) — 2020 has been […]

Read More